Molecular profiles in foregut oncology.

Area of Science:

• * Oncology
• * Molecular biology
• * Precision medicine

Background:

• * Oncology is rapidly evolving due to advances in understanding cancer biology and genetics.
• * Precision medicine, utilizing tumor biomarkers and targeted therapies, is becoming central to cancer care.
• * Physicians need to understand and communicate the role of molecular markers and targeted strategies to patients.

Purpose of the Study:

• * To identify and characterize clinically relevant molecular markers in cancer.
• * To review literature supporting targeted interventions based on these markers.
• * To examine the efficacy of marker-targeted treatments in specific gastrointestinal and liver cancers.

Main Methods:

• * Literature review and characterization of scientific publications.
• * Analysis of clinical trial data.
• * Focus on esophageal, gastric, liver, gallbladder, biliary tract, and pancreatic cancers.

Main Results:

• * Identification of key molecular markers across various gastrointestinal and liver cancers.
• * Evaluation of targeted therapy efficacy based on clinical trial outcomes.
• * Discussion of the clinical relevance of identified markers and interventions.

Conclusions:

• * Understanding molecular markers and targeted therapies is crucial for modern oncology.
• * Evidence supports the efficacy of specific marker-targeted treatments for esophageal, gastric, liver, biliary, and pancreatic cancers.
• * This review provides a foundation for integrating precision medicine strategies into clinical practice.